-
Christine Willgoos
-
- Special Counsel
- New York
- Download vcard
-
Christine Willgoos litigates patent actions on behalf of pharmaceutical and biotechnology companies, leading trial and appellate teams in Hatch-Waxman and biologic drug litigation, often involving blockbuster drugs. She represents biotechnology companies, including advising on biosimilar litigation. Christine is an accomplished courtroom advocate with significant experience, including trials and appeals, preliminary injunctions, and Markman hearings. She has handled cases in genetics, molecular biology, biochemistry and drug development, including those concerning biologic drugs, recombinant DNA vectors, cancer drugs, antidepressant drugs and dermatologic drugs. Her work extends across other industries as well, including medical devices, semiconductors, telecommunications and electronics.
Experience
-
Representing a pharmaceutical company in Hatch-Waxman litigation concerning a breakthrough, blockbuster cancer drug.
-
Representing a pharmaceutical company with respect to combination drugs to treat HIV/AIDS.
-
Represented a medical diagnostics company in patent litigation concerning next generation sequencing.
Credentials
Education
-
J.D., cum laude, Boston University School of Law, 2001 -
G. Joseph Tauro Scholar
-
Paul J. Liacos Scholar
-
American Journal of Law and Medicine, Staff Editor
-
-
Master of Forensic Science, Forensic Molecular Biology, George Washington University, 1997 -
B.S., Biochemistry, State University of New York at Geneseo, 1995
Bar Admissions
-
New York, 2002
Court Admissions
- U.S.C.A., Federal Circuit
- U.S.D.C., Eastern District of New York
- U.S.D.C., Southern District of New York
- U.S. Patent & Trademark Office
Professional Affiliations
- New York City Bar Association, Science and Law Committee
- New York Intellectual Property Law Association, Programs Committee
- New Jersey Intellectual Property Law Association
Focus Areas
-
-
-